A2M and focal segmental glomerulosclerosis: Indeed, two focal segmental glomerulosclerosis (FSGS) patient subgroups were identified based on alpha‐2 macroglobulin (A2M) expression, which was associated with proteinuria remission rates and long‐term renal outcomes [140].